{"id":72883,"date":"2023-08-23T15:39:37","date_gmt":"2023-08-23T10:09:37","guid":{"rendered":"http:\/\/finservwealth.com\/jb-chemicals-gets-usfda-nod-to-market-generic-medication\/"},"modified":"2023-08-23T15:39:37","modified_gmt":"2023-08-23T10:09:37","slug":"jb-chemicals-gets-usfda-nod-to-market-generic-medication","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/jb-chemicals-gets-usfda-nod-to-market-generic-medication\/","title":{"rendered":"JB Chemicals gets USFDA nod to market generic medication"},"content":{"rendered":"<p> The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals  Pharmaceuticals said in a regulatory filing.<\/p><div id=\"finse-820874897\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/jb-chemicals-gets-usfda-nod-to-market-generic-medication_17216691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals  Pharmaceuticals said in a regulatory filing. The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals  Pharmaceuticals said in a regulatory filing.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/jb-chemicals-gets-usfda-nod-to-market-generic-medication_17216691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals  Pharmaceuticals said in a regulatory filing.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/jb-chemicals-gets-usfda-nod-to-market-generic-medication_17216691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals  Pharmaceuticals said in a regulatory filing. The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals  Pharmaceuticals said in a regulatory filing.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/jb-chemicals-gets-usfda-nod-to-market-generic-medication_17216691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals  Pharmaceuticals said in a regulatory filing.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-72883","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/N\/Neogen-Chemicals_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/72883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=72883"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/72883\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=72883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=72883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=72883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}